Point72 Asset Management
TWST icon

Point72 Asset Management’s Twist Bioscience TWST Stock Holding History

Point72 Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,000
Closed -$2.06M – 2461
2024
Q1 		$2.06M Sell
60,000
-50,000
-45% -$1.8M 0.01% 1258
2023
Q4 		$4.05M Buy
+110,000
New +$2.54M 0.01% 1001

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Point72 Asset Management's TWST Position: Q2 2026 in Review

Point72 Asset Management sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 669,732 shares — an estimated $31.8M sold.

Point72 Asset Management first reported a position in TWST in Q1 2022 and held it in 9 quarters. The position peaked at $79.4M in Q2 2025. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Point72 Asset Management reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 669,732 Twist Bioscience shares in Q2 2026, an estimated $31.8M.
  • Point72 Asset Management first reported a position in Twist Bioscience in Q1 2022 and held it in 9 quarters.
  • Point72 Asset Management's Twist Bioscience position peaked at $79.4M in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.